PUBLICATION
Iroquois Homeobox 1 Acts as a True Tumor Suppressor in Multiple Organs by Regulating Cell Cycle Progression
- Authors
- Jung, I.H., Jung, D.E., Chung, Y.Y., Kim, K.S., Park, S.W.
- ID
- ZDB-PUB-190827-4
- Date
- 2019
- Source
- Neoplasia (New York, N.Y.) 21: 1003-1014 (Journal)
- Registered Authors
- Park, Seung Woo
- Keywords
- none
- MeSH Terms
-
- Animals
- Cell Cycle/genetics*
- Cell Line, Tumor
- Cell Transformation, Neoplastic/genetics
- Cell Transformation, Neoplastic/metabolism
- Gene Expression
- Gene Expression Profiling
- Gene Knockout Techniques
- Gene Targeting
- Genes, Tumor Suppressor*
- Genetic Loci
- Homeodomain Proteins/genetics*
- Homeodomain Proteins/metabolism
- Humans
- Immunohistochemistry
- Immunophenotyping
- Organ Specificity/genetics
- Phenotype
- Transcription Factors/genetics*
- Transcription Factors/metabolism
- Zebrafish
- PubMed
- 31450023 Full text @ Neoplasia
Citation
Jung, I.H., Jung, D.E., Chung, Y.Y., Kim, K.S., Park, S.W. (2019) Iroquois Homeobox 1 Acts as a True Tumor Suppressor in Multiple Organs by Regulating Cell Cycle Progression. Neoplasia (New York, N.Y.). 21:1003-1014.
Abstract
Iroquois homeobox 1 (IRX1) belongs to the Iroquois homeobox family known to play an important role during embryonic development. Interestingly, however, recent studies have suggested that IRX1 also acts as a tumor suppressor. Here, we use homozygous knockout mutants of zebrafish to demonstrate that the IRX1 gene is a true tumor suppressor gene and mechanism of the tumor suppression is mediated by repressing cell cycle progression. In this study, we found that knockout of zebrafish Irx1 gene induced hyperplasia and tumorigenesis in the multiple organs where the gene was expressed. On the other hands, overexpression of the IRX1 gene in human tumor cell lines showed delayed cell proliferation of the tumor cells. These results suggest that the IRX1 gene is truly involved in tumor suppression. In an attempt to identify the genes regulated by the transcription factor IRX1, we performed microarray assay using the cRNA obtained from the knockout mutants. Our result indicated that the highest fold change of the differential genes fell into the gene category of cell cycle regulation, suggesting that the significant canonical pathway of IRX1 in antitumorigenesis is done by regulating cell cycle. Experiment with cell cycle blockers treated to IRX1 overexpressing tumor cells showed that the IRX1 overexpression actually delayed the cell cycle. Furthermore, Western blot analysis with cyclin antibodies showed that IRX1 overexpression induced decrease of cyclin production in the cancer cells. In conclusion, our in vivo and in vitro studies revealed that IRX1 gene functionally acts as a true tumor suppressor, inhibiting tumor cell growth by regulating cell cycle.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping